Skip to content
1st Counsel – Lifestyle
Author:
Handa Pharma, Inc.
Handa Oncology Receives FDA Final Approval for OMCAZIO(TM) (cabozantinib) Capsules
September 11, 2026
Handa Oncology Receives FDA Tentative Approval for OMCAZIO (cabozantinib) Capsules
July 31, 2026